Why is Hamps Bio falling/rising?

As of 01-Aug, Hamps Bio Limited's stock is currently priced at Rs 52.49, reflecting a decrease of Rs 2.76 or 5.0%. The stock has underperformed its sector by 1.84% today and opened with a loss of 3.17%. It reached an intraday low of Rs 52.49, indicating significant downward pressure. Over the past week, the stock has experienced a substantial decline of 18.76%, while it has shown a positive return of 34.59% over the past month. However, year-to-date, it is down 36.51%. The stock's trading activity has been erratic, with it not trading on one day out of the last 20, and there has been a notable drop in investor participation, with delivery volume falling by 84.38% against the 5-day average.
In the broader market context, the Sensex has only declined by 1.06% over the past week, indicating that Hamps Bio's performance is significantly lagging behind the benchmark. The Pharmaceuticals & Drugs sector has also seen a decline of 3.26%, which may be contributing to the stock's downward movement. Despite being liquid enough for trading, the stock's performance is concerning given the broader market's relatively stable condition. Overall, the combination of poor trading volume, significant losses in both short-term and year-to-date performance, and sector-wide declines are likely driving the stock's current downward trajectory.